- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/06 - Antiglaucoma agents or miotics
Patent holdings for IPC class A61P 27/06
Total number of patents in this class: 1669
10-year publication summary
|
73
|
84
|
63
|
96
|
101
|
105
|
140
|
127
|
94
|
45
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2600 |
154 |
| Santen Pharmaceutical Co., Ltd. | 649 |
77 |
| Nicox S.A. | 149 |
32 |
| Aerie Pharmaceuticals, Inc. | 131 |
21 |
| Kowa Company, Ltd. | 1172 |
21 |
| Senju Pharmaceutical Co., Ltd. | 234 |
19 |
| Alcon Research, Ltd. | 352 |
15 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
15 |
| Alcon, Inc. | 4899 |
13 |
| Ono Pharmaceutical Co., Ltd. | 454 |
13 |
| The Regents of the University of California | 18943 |
12 |
| Takeda Pharmaceutical Company Limited | 2961 |
12 |
| Bausch & Lomb Incorporated | 1199 |
12 |
| D. Western Therapeutics Institute, Inc. | 23 |
10 |
| Daiichi Sankyo Company, Limited | 1829 |
10 |
| Japan Tobacco Inc. | 3225 |
10 |
| Novartis AG | 11238 |
9 |
| Astellas Pharma Inc. | 1145 |
9 |
| Dainippon Sumitomo Pharma Co., Ltd. | 234 |
8 |
| Eye Therapies LLC | 37 |
8 |
| Other owners | 1189 |